摘要
目的分析在盆腔炎患者治疗中联合应用盐酸左氧氟沙星与甲硝唑进行治疗的效果。方法选取2015年6月至2016年6月在我院治疗的80例盆腔炎患者,根据治疗方式不同分为两组,各40例。对照组使用甲硝唑治疗,观察组联合应用盐酸左氧氟沙星与甲硝唑治疗,观察两组患者治疗的效果。结果观察组患者治疗的总有效率较对照组高,差异具有统计学意义(P<0.05);观察组患者接受治疗后的疾病复发情况明显比对照组低,差异具有统计学意义(P<0.05);观察组患者治疗的总满意度明显比对照组高,差异具有统计学意义(P<0.05);观察组不良反应发生率是2.50%,显著低于对照组的12.5%,差异具有统计学意义(P<0.05)。结论在盆腔炎患者治疗中联合应用盐酸左氧氟沙星与甲硝唑进行治疗,可以提高患者临床治疗的效果,降低不良反应发生率与复发率,具有临床应用的价值。
Objective To evaluate the therapeutic effect of levofloxacin hydrochloride combined with metronidazole on patients with pelvic inflammatory disease. Methods From June 2015 to June 2016, 80 cases of pelvic inflammatory disease patients according to treatment methods were divided into observation group and control group, 40 cases in each group. The control group used metronidazole treatment, and the observation group received levofloxacin hydrochloride combined with metronidazole, the treatment effects were compared between the two groups. Results The efficiency of the observation group was higher than that of the control group, the difference was statistically significant （P〈0.05）; the recurrence rate of the observation group was significantly lower than that of the control group, the difference was statisticaly significant （P〈0.05）; the satisfaction rate of the observation group was significantly higher than that of the control group （P〈0.05）; the incidence of adverse reactions in the observation group was 2.50%, which was significantly lower than 12.50% of the control group, the difference was statisticaly significant （P〈0.05）. Conclusion Levofloxacin combined with metronidazole in the treatment of patients with pelvic inflammatory disease can improve the clinical treatment effect, reduce the incidence of adverse reactions and recurrence rate, which has the value of clinical application.
出处
《临床医学研究与实践》
2017年第4期86-87,共2页
Clinical Research and Practice
关键词
盐酸左氧氟沙星
甲硝唑
盆腔炎
levofloxacin hydrochloride
metronidazole
pelvic inflammatory disease
